3rd Aug 2015 3:00 pm |
RNS |
Total Voting Rights |
30th Jul 2015 7:01 am |
RNS |
Half Yearly Report |
29th Jul 2015 9:00 am |
RNS |
Notice of Results |
27th Jul 2015 11:00 am |
RNS |
Confirmation of Change in ADS Ratio |
27th Jul 2015 7:00 am |
RNS |
AstraZeneca agreement with Genzyme on Caprelsa |
22nd Jul 2015 7:00 am |
RNS |
AstraZeneca commences Phase II Trial |
17th Jul 2015 11:00 am |
RNS |
Holding(s) in Company |
17th Jul 2015 7:05 am |
RNS |
AZ completes agreement with Tillotts for Entocort |
14th Jul 2015 7:00 am |
RNS |
IRESSA approved by US FDA |
9th Jul 2015 7:32 am |
RNS |
Agreement with Tillotts on Entocort |
1st Jul 2015 11:00 am |
RNS |
Total Voting Rights |
26th Jun 2015 12:00 pm |
RNS |
Change in ADS ratio |
25th Jun 2015 11:30 am |
RNS |
Publication of Prospectus |
16th Jun 2015 2:00 pm |
RNS |
Director/PDMR Shareholding |
3rd Jun 2015 3:00 pm |
RNS |
Holding(s) in Company |
1st Jun 2015 3:00 pm |
RNS |
Total Voting Rights |
1st Jun 2015 3:00 pm |
RNS |
AstraZeneca PLC - Blocklisting Interim Review |
26th May 2015 7:01 am |
RNS |
UPDATE ON BRODALUMAB DEVELOPMENT PROGRAMME |
18th May 2015 10:07 am |
RNS |
AstraZeneca to invest £182m to expand drug plant in Sweden |
13th May 2015 3:00 pm |
RNS |
Holding(s) in Company |
8th May 2015 2:00 pm |
RNS |
Director/PDMR Shareholding |
8th May 2015 11:00 am |
RNS |
Director/PDMR Shareholding - Replacement |
8th May 2015 10:00 am |
RNS |
Director/PDMR Shareholding |
7th May 2015 2:00 pm |
RNS |
Director Declaration |
1st May 2015 4:00 pm |
RNS |
Director/PDMR Shareholding |
1st May 2015 11:00 am |
RNS |
Total Voting Rights |
29th Apr 2015 5:30 pm |
RNS |
Director/PDMR Shareholding |
24th Apr 2015 5:30 pm |
RNS |
Result of AGM |
24th Apr 2015 7:02 am |
RNS |
1st Quarter Results |
24th Apr 2015 7:01 am |
RNS |
Collaboration with Celgene on PD-L1 in haematology |
24th Apr 2015 7:00 am |
RNS |
AZ and Innate to collaborate in immuno-oncology |
23rd Apr 2015 9:00 am |
RNS |
Notice of Results |
17th Apr 2015 7:00 am |
RNS |
Selumetinib granted Orphan Drug Designation by FDA |
15th Apr 2015 7:02 am |
RNS |
Tremelimumab granted Orphan Drug Designation |
15th Apr 2015 7:00 am |
RNS |
FDA REVIEWS SAVOR OUTCOMES STUDY RESULTS |
1st Apr 2015 11:00 am |
RNS |
Total Voting Rights |
30th Mar 2015 3:00 pm |
RNS |
Director/PDMR Shareholding |
19th Mar 2015 11:00 am |
RNS |
Notice of AGM |
19th Mar 2015 7:00 am |
RNS |
COLLABORATION WITH DAIICHI SANKYO INC |
18th Mar 2015 7:04 am |
RNS |
POSITIVE PHASE III RESULTS FOR PT003 IN COPD |